ATP as a marker of excitotoxin-induced nerve cell death in vivo
- 1 September 1987
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 70 (3-4) , 349-356
- https://doi.org/10.1007/bf01253609
Abstract
In an attempt to find an marker for nerve cell death in vivo, the ATP content was measured in the rat dorsal hippocampus within hours or days following in the local injection of the excitotoxins quinolinic or kainic acid. Beginning or completed neuronal degeneration is accompanied by significant decreases in ATP levels. Selective blockade of the quinolinic acid-induced decrement in ATP content by D-(−) 2-amino-7-phosphonoheptanoic acid indicates that ATP measurements may of value for the rapid in vivo screening of the anti-neurotoxic properties of pharmacologically distinct excitatory amino acid receptor antagonists.This publication has 22 references indexed in Scilit:
- EXCITATORY AMINOACID ANTAGONISTS PROVIDE A THERAPEUTIC APPROACH TO NEUROLOGICAL DISORDERSThe Lancet, 1985
- II. Excitotoxic models for neurodegenerative disordersLife Sciences, 1984
- Seizure activity and lesions after intrahippocampal quinolinic acid injectionExperimental Neurology, 1984
- Receptors for the excitatory amino acids in the mammalian central nervous systemProgress in Neurobiology, 1983
- On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compoundsNeuropharmacology, 1983
- Effects of Kainic Acid on High‐Energy Metabolites in the Mouse StriatumJournal of Neurochemistry, 1982
- Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNSEuropean Journal of Pharmacology, 1981
- Kainic acid lesion of mouse striatum: Effects on energy metabolitesLife Sciences, 1980
- Reversed phase high performance liquid chromatographic separations of nucleotides in the presence of solvophobic ionsAnalytical Chemistry, 1977
- Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: Correlates with a new animal modelProgress in Neuro-Psychopharmacology, 1977